TABLE OF CONTENTS
1 INTRODUCTION 29
1.1 OBJECTIVES OF THE STUDY 29
1.2 MARKET DEFINITION 29
1.3 OVERVIEW OF THE EUROPE LAB AUTOMATION MARKET 29
1.4 LIMITATIONS 31
1.5 MARKETS COVERED 31
2 MARKET SEGMENTATION 33
2.1 MARKETS COVERED 33
2.2 GEOGRAPHICAL SCOPE 34
2.3 YEARS CONSIDERED FOR THE STUDY 35
2.4 CURRENCY AND PRICING 35
2.5 DBMR TRIPOD DATA VALIDATION MODEL 36
2.6 MULTIVARIATE MODELLING 39
2.7 PRODUCT TYPE LIFELINE CURVE 39
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 40
2.9 DBMR MARKET POSITION GRID 41
2.10 MARKET END USER COVERAGE GRID 42
2.11 VENDOR SHARE ANALYSIS 43
2.12 SECONDARY SOURCES 44
2.13 ASSUMPTIONS 44
3 EXECUTIVE SUMMARY 45
4 PREMIUM INSIGHTS 47
4.1 PESTEL ANALYSIS 48
4.2 PORTERS FIVE FORCES 49
5 REGULATION 50
6 MARKET OVERVIEW 52
6.1 DRIVERS 54
6.1.1 INCREASING INVESTMENT & STRATEGIC INITIATIVES BY MARKET PLAYERS 54
6.1.2 GOVERNMENT INITIATIVES TO STRENGTHEN LABORATORY INFRASTRUCTURES 54
6.1.3 GROWING EXPENDITURE ON LAB AUTOMATION TOOLS AND EQUIPMENT 54
6.1.4 REDUCING HUMAN EFFORTS AND ELIMINATING HUMAN ERROR 55
6.2 RESTRAINTS 55
6.2.1 LIMITATION ANALYZING NOVEL COMPLEX PRODUCT 55
6.2.2 HIGH COST FOR INSTALLATION AND SETUP 55
6.2.3 UPGRADATION, MAINTENANCE, AND PERIODICAL CHECKUPS 56
6.3 OPPORTUNITIES 56
6.3.1 RISING HEALTHCARE EXPENDITURE 56
6.3.2 STRATEGIC INITIATIVES BY KEY PLAYERS 57
6.3.3 RISE IN THE NUMBER OF PHARMA COMPANIES 57
6.4 CHALLENGES 58
6.4.1 SLOW ADOPTION OF AUTOMATION AMONG SMALL AND MEDIUM SIZED LABORATORIES 58
6.4.2 LIMITED FEASIBILITY WITH TECHNOLOGY INTEGRATION IN ANALYTICAL LABS 58
7 EUROPE LAB AUTOMATION MARKET, BY PRODUCT TYPE 59
7.1 OVERVIEW 60
7.2 EQUIPMENT 63
7.2.1 AUTOMATED WORKSTATIONS 63
7.2.1.1 AUTOMATED LIQUID HANDLING SYSTEMS 63
7.2.1.2 AUTOMATED INTEGRATED WORKSTATIONS 63
7.2.1.3 PIPETTING SYSTEMS 64
7.2.1.4 MICROPLATE WASHERS 64
7.2.1.5 REAGENT DISPENSERS 64
7.2.2 MICROPLATE READERS 64
7.2.2.1 MULTI-MODE MICROPLATE READERS 64
7.2.2.2 SINGLE-MODE MICROPLATE READERS 64
7.2.2.3 AUTOMATED NUCLEIC ACID PURIFICATION SYSTEMS 64
7.2.2.4 AUTOMATED ELISA SYSTEMS 65
7.2.3 OFF-THE-SHELF AUTOMATED WORKCELLS 65
7.2.4 ROBOTIC SYSTEMS 65
7.2.4.1 ROBOTIC ARMS 65
7.2.4.2 TRACK ROBOTS 65
7.2.5 AUTOMATE STORAGE & RETRIEVALS (ASRS) 65
7.2.6 OTHERS 65
7.3 ANALYZER 65
7.3.1 BIO CHEMISTRY ANALYZERS 66
7.3.2 HAEMATOLOGY ANALYZERS 66
7.3.3 IMMUNO-BASED ANALYZERS 66
7.4 SOFTWARE & INFORMATICS 66
7.4.1 LABORATORY INFORMATION MANAGEMENT SYSTEM (LIMS) 67
7.4.2 ELECTRONIC LABORATORY NOTEBOOK (ELN) 67
7.4.3 LABORATORY EXECUTION SYSTEMS (LES) 67
7.4.4 SCIENTIFIC DATA MANAGEMENT SYSTEMS (SDMS) 68
8 EUROPE LAB AUTOMATION MARKET, BY AUTOMATION TYPE 69
8.1 OVERVIEW 70
8.2 TOTAL LAB AUTOMATION 73
8.3 MODULAR AUTOMATION 73
9 EUROPE LAB AUTOMATION MARKET, BY APPLICATION 74
9.1 OVERVIEW 75
9.2 CLINICAL DIAGNOSTICS 78
9.3 DRUG DISCOVERY 78
9.4 GENOMICS SOLUTIONS 78
9.5 PROTEOMIC SOLUTIONS 79
9.6 ANALYTICAL CHEMISTRY 79
9.7 PROTEIN ENGINEERING 80
9.8 BIO ANALYSIS 80
9.9 SYSTEM BIOLOGY 81
9.10 OTHERS 81
10 EUROPE LAB AUTOMATION MARKET, BY END USER 83
10.1 OVERVIEW 84
10.2 BIOTECHNOLOGY & PHARMACEUTICALS 87
10.3 HOSPITALS & LABORATORIES 87
10.4 RESEARCH & ACADEMIC INSTITUTES 87
10.5 OTHERS 88
11 EUROPE LAB AUTOMATION MARKET, BY REGION 89
11.1 EUROPE 90
11.1.1 GERMANY 98
11.1.2 FRANCE 101
11.1.3 U.K. 105
11.1.4 ITALY 109
11.1.5 RUSSIA 113
11.1.6 SPAIN 117
11.1.7 NETHERLANDS 120
11.1.8 SWITZERLAND 124
11.1.9 TURKEY 128
11.1.10 BELGIUM 132
11.1.11 REST OF EUROPE 136
12 EUROPE LAB AUTOMATION MARKET: COMPANY LANDSCAPE 137
12.1 COMPANY SHARE ANALYSIS: EUROPE 137
13 SWOT ANALYSIS 138
14 COMPANY PROFILE 139
14.1 THERMO FISHER SCIENTIFIC INC. 139
14.1.1 COMPANY SNAPSHOT 139
14.1.2 REVENUE ANALYSIS 140
14.1.3 COMPANY SHARE ANALYSIS 140
14.1.4 PRODUCT PORTFOLIO 140
14.1.5 RECENT DEVELOPMENTS 141
14.2 DANAHER 142
14.2.1 COMPANY SNAPSHOT 142
14.2.2 REVENUE ANALYSIS 142
14.2.3 COMPANY SHARE ANALYSIS 143
14.2.4 PRODUCT PORTFOLIO 143
14.2.5 RECENT DEVELOPMENTS 143
14.3 F. HOFFMANN- LA ROCHE LTD 144
14.3.1 COMPANY SNAPSHOT 144
14.3.2 REVENUE ANALYSIS 144
14.3.3 COMPANY SHARE ANALYSIS 145
14.3.4 PRODUCT PORTFOLIO 145
14.3.5 RECENT DEVELOPMENTS 145
14.4 PERKINELMER INC 147
14.4.1 COMPANY SNAPSHOT 147
14.4.2 REVENUE ANALYSIS 148
14.4.3 COMPANY SHARE ANALYSIS 148
14.4.4 PRODUCT PORTFOLIO 149
14.4.5 RECENT DEVELOPMENTS 149
14.5 BD 150
14.5.1 COMPANY SNAPSHOT 150
14.5.2 REVENUE ANALYSIS 150
14.5.3 COMPANY SHARE ANALYSIS 151
14.5.4 PRODUCT PORTFOLIO 151
14.5.5 RECENT DEVELOPMENTS 151
14.6 ABBOTT 152
14.6.1 COMPANY SNAPSHOT 152
14.6.2 REVENUE ANALYSIS 152
14.6.3 PRODUCT PORTFOLIO 153
14.6.3 RECENT DEVELOPMENTS 153
14.7 AGILENT TECHNOLOGIES 154
14.7.1 COMPANY SNAPSHOT 154
14.7.2 REVENUE ANALYSIS 154
14.7.3 PRODUCT PORTFOLIO 155
14.7.4 RECENT DEVELOPMENTS 155
14.8 AURORA BIOMED INC. 156
14.8.1 COMPANY SNAPSHOT 156
14.8.2 PRODUCT PORTFOLIO 156
14.8.3 RECENT DEVELOPMENTS 156
14.9 AZENTA US INC 157
14.9.1 COMPANY SNAPSHOT 157
14.9.2 REVENUE ANALYSIS 157
14.9.3 PRODUCT PORTFOLIO 158
14.9.4 RECENT DEVELOPMENTS 158
14.10 BIOMERIEUX 159
14.10.1 COMPANY SNAPSHOT 159
14.10.2 REVENUE ANALYSIS 159
14.10.3 PRODUCT PORTFOLIO 160
14.10.4 RECENT DEVELOPMENTS 160
14.11 EPPENDORF SE 161
14.11.1 COMPANY SNAPSHOT 161
14.11.2 PRODUCT PORTFOLIO 161
14.11.3 RECENT DEVELOPMENTS 161
14.12 HAMILTON COMPANY 162
14.12.1 COMPANY SNAPSHOT 162
14.12.2 PRODUCT PORTFOLIO 162
14.12.3 RECENT DEVELOPMENTS 162
14.13 HUDSON ROBOTICS 163
14.13.1 COMPANY SNAPSHOT 163
14.13.2 PRODUCT PORTFOLIO 163
14.13.3 RECENT DEVELOPMENTS 163
14.14 LABLYNX LIMS 164
14.14.1 COMPANY SNAPSHOT 164
14.14.2 PRODUCT PORTFOLIO 164
14.14.3 RECENT DEVELOPMENTS 164
14.15 LABVANTAGE SOLUTIONS INC. 165
14.15.1 COMPANY SNAPSHOT 165
14.15.2 PRODUCT PORTFOLIO 165
14.15.3 RECENT DEVELOPMENTS 165
14.16 LABWARE 166
14.16.1 COMPANY SNAPSHOT 166
14.16.2 PRODUCT PORTFOLIO 166
14.16.3 RECENT DEVELOPMENTS 166
14.17 QIAGEN 167
14.17.1 COMPANY SNAPSHOT 167
14.17.2 REVENUE ANALYSIS 167
14.17.3 PRODUCT PORTFOLIO 168
14.17.4 RECENT DEVELOPMENTS 168
14.18 SIEMENS HEALTHCARE GMBH 170
14.18.1 COMPANY SNAPSHOT 170
14.18.2 REVENUE ANALYSIS 170
14.18.3 PRODUCT PORTFOLIO 171
14.18.4 RECENT DEVELOPMENTS 171
14.19 TECAN TRADING AG 172
14.19.1 COMPANY SNAPSHOT 172
14.19.2 REVENUE ANALYSIS 172
14.19.3 PRODUCT PORTFOLIO 173
14.19.4 RECENT DEVELOPMENTS 173
15 QUESTIONNAIRE 174
16 RELATED REPORTS 177

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.